Literature DB >> 33990208

Elevated sweat chloride test: is it always cystic fibrosis?

C Cimbalo1, A Tosco2, V Terlizzi3, A Sepe2, A Castaldo2, L Salvadori2, V Raia2.   

Abstract

BACKGROUND: The sweat chloride test (ST) is the gold standard for cystic fibrosis (CF) diagnosis in symptomatic patients, within the newborn screening and in the follow-up of CF patients during molecular therapies. However, false positives have been reported in patients with different diseases. We describe and discuss 4 cases due to different clinical conditions in which we recorded false positive ST, and the test remained altered for a period of varying length. CASES
PRESENTATION: Case 1: Eight months old female child suffering from constipation, recurrent vomiting and failure to thrive, family history of recurrent pancreatitis without mutations in the PRSS1 and SPINK1 genes. Both ST and fecal elastase were altered although no CFTR gene mutations were found. Due to rapid clinical deterioration, celiac disease was suspected and diagnosed by laboratory tests and intestinal biopsy. After 2 weeks of gluten-free diet ST and fecal elastase normalized. Case 2: 14 months old male suffering from bilateral renal dysplasia, episodes of metabolic alkalosis, recurrent respiratory infections and recurrent vomiting. The child had more ST positives, but no CFTR mutations were found. During follow-up, he developed sensorineural hearing loss and an atrial septic defect was found. Finally, a diagnosis of Klinefelter was made, but the ST normalized several years later. Case 3 and 4: Two boys with stubborn constipation and fecal occlusion treated with Poly Ethylene Glycol (PEG) with salts showed pathological ST. The test returned normal a few days after stopping treatment.
CONCLUSIONS: We hypotesized the possible causes of ST alteration in these conditions: in celiac disease it could be due to a transient dysregulation of the aquaporins, rapidly reversed by the diet; in Klinefelter, it may be due to stable pubertal hypoandrogenism; while, the PEG formulation itself contains salts that can temporarily alter ST.

Entities:  

Keywords:  Celiac disease; Cystic fibrosis; False positive; Klinefelter syndrome; Sweat chloride test

Year:  2021        PMID: 33990208     DOI: 10.1186/s13052-021-01060-1

Source DB:  PubMed          Journal:  Ital J Pediatr        ISSN: 1720-8424            Impact factor:   2.638


  15 in total

1.  A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis.

Authors:  L E GIBSON; R E COOKE
Journal:  Pediatrics       Date:  1959-03       Impact factor: 7.124

2.  Quality assessment in cytogenetic and molecular genetic testing: the experience of the Italian Project on Standardisation and Quality Assurance.

Authors:  Domenica Taruscio; Vincenzo Falbo; Giovanna Floridia; Marco Salvatore; Chiara Pescucci; Alfredo Cantafora; Cesarina Marongiu; Anna Baroncini; Elisa Calzolari; Antonio Cao; Giuseppe Castaldo; Franca Dagna Bricarelli; Ginevra Guanti; Lucio Nitsch; Pier Franco Pignatti; Cristina Rosatelli; Francesco Salvatore; Orsetta Zuffardi
Journal:  Clin Chem Lab Med       Date:  2004       Impact factor: 3.694

3.  Lack of harmonization in sweat testing for cystic fibrosis - a national survey.

Authors:  Anne Lindegaard Christiansen; Mads Nybo
Journal:  Scand J Clin Lab Invest       Date:  2014-09-09       Impact factor: 1.713

4.  Trend of sweat chloride values in a cohort of patients carrying CFTR mutations of varying clinical consequence: Is there a risk of increasing sweat chloride over time?

Authors:  Vito Terlizzi; Gianfranco Mergni; Claudia Centrone; Filippo Festini; Giovanni Taccetti
Journal:  Pediatr Pulmonol       Date:  2020-03-09

5.  Multicenter validation study for the certification of a CFTR gene scanning method using next generation sequencing technology.

Authors:  Anne Bergougnoux; Valeria D'Argenio; Stefanie Sollfrank; Fanny Verneau; Antonella Telese; Irene Postiglione; Karl J Lackner; Mireille Claustres; Giuseppe Castaldo; Heidi Rossman; Francesco Salvatore; Caroline Raynal
Journal:  Clin Chem Lab Med       Date:  2018-06-27       Impact factor: 3.694

6.  The CFTR 3849+10kbC->T and 2789+5G->A alleles are associated with a mild CF phenotype.

Authors:  I Duguépéroux; M De Braekeleer
Journal:  Eur Respir J       Date:  2005-03       Impact factor: 16.671

7.  Extensive molecular analysis of patients bearing CFTR-related disorders.

Authors:  Felice Amato; Chiara Bellia; Giuseppe Cardillo; Giuseppe Castaldo; Marcello Ciaccio; Ausilia Elce; Francesca Lembo; Rossella Tomaiuolo
Journal:  J Mol Diagn       Date:  2011-10-20       Impact factor: 5.568

8.  Misdiagnosis of cystic fibrosis: experience from Germany.

Authors:  Lutz Naehrlich; Azadeh Bagheri-Behrouzi
Journal:  J Cyst Fibros       Date:  2012-07-24       Impact factor: 5.482

Review 9.  Transient elevation of sweat chloride concentration in a malnourished girl with the Mauriac syndrome.

Authors:  F P Polack; D J Transue; W M Belknap; B J Freij; D J Aughton
Journal:  J Pediatr       Date:  1995-02       Impact factor: 4.406

Review 10.  The future of cystic fibrosis care: a global perspective.

Authors:  Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2019-09-27       Impact factor: 30.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.